Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 9/20 | 0.47 |
| ▸ | EGLN2 | Q96KS0 | 4/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.47 |
| ▸ | APLNR | P35414 | 3/20 | 0.45 |
| ▸ | PRNP | P04156 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | EEF2K | O00418 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15637008 | 0.93 | CTSA (0.53) | CTSAAPLNRPRNPNPSR1RXFP1 | |
| SCHEMBL15636578 | 0.92 | EGLN2 (0.52) | CTSAEGLN2EGLN1EEF2K | |
| SCHEMBL15637214 | 0.90 | EGLN2 (0.45) | CTSAEGLN2EGLN1EEF2K | |
| SCHEMBL15637118 | 0.90 | APLNR (0.45) | CTSAEGLN2EGLN1APLNR | |
| SCHEMBL15636670 | 0.90 | EGLN2 (0.49) | CTSAEGLN2EGLN1EEF2K | |
| SCHEMBL15637366 | 0.90 | CTSA (0.52) | CTSAAPLNRPRNPNPSR1RXFP1 | |
| SCHEMBL15637296 | 0.90 | CTSA (0.54) | CTSAAPLNRPRNPNPSR1RXFP1 | |
| SCHEMBL15636963 | 0.90 | CTSA (0.54) | CTSAAPLNRPRNPNPSR1RXFP1 | |
| SCHEMBL16223863 | 0.88 | CTSA (0.54) | CTSAAPLNR | |
| SCHEMBL15636772 | 0.88 | CTSA (0.52) | CTSAAPLNRPRNPNPSR1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014053533-A1 | USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION | SANOFI (FR) | 2014-04-10 | — | — | WO | disclosed |